Literature DB >> 10952681

Characterization of prostanoid receptors mediating actions of the isoprostanes, 8-iso-PGE(2) and 8-iso-PGF(2alpha), in some isolated smooth muscle preparations.

W Sametz1, S Hennerbichler, S Glaser, R Wintersteiger, H Juan.   

Abstract

We investigated the contracting actions of the isoprostanes (isoPs), 8-iso-prostaglandin (PG) F(2alpha) and 8-iso-PGE(2), in comparison to the effects of the thromboxane (TX) A(2)-mimetic U 46619 and the traditional prostaglandin PGE(2) in the isolated rat aorta, isolated rat gastric fundus and the isolated guinea-pig ileum. U 46619 and 8-iso-PGF(2alpha) caused contractions in the rat aorta and rat gastric fundus in a concentration-dependent manner, whereas these agonists showed no effects in the guinea-pig ileum. However, 8-iso-PGE(2) and PGE(2) caused contractions in all isolated organs used. The prostanoid TP-receptor antagonist SQ 29,548 (10 nM) significantly antagonized vasoconstrictions induced by the agonists used in the rat aorta. SQ 29,548 at a final concentration of 3 microM, but not at lower concentrations, significantly inhibited contractions induced by U 46619, 8-iso-PGF(2alpha) and 8-iso-PGE(2) in the rat fundus. Responses to PGE(2) were unchanged. The prostanoid EP(1)-receptor antagonist SC 51089 (3 microM) significantly inhibited contractions induced by 8-iso-PGE(2) and PGE(2) in the rat fundus and in the guinea-pig ileum. SC 51089 had no effect on responses to any of the agonists tested. Our results show that 8-iso-PGE(2), in contrast to 8-iso-PGF(2alpha), can also cause contractions by activation of the EP(1)-receptors in the rat gastric fundus and the guinea-pig ileum. The findings of the present study do not support the existence of a unique isoP-receptor in the tissues used.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952681      PMCID: PMC1572277          DOI: 10.1038/sj.bjp.0703522

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids.

Authors:  J D Morrow; T M Harris; L J Roberts
Journal:  Anal Biochem       Date:  1990-01       Impact factor: 3.365

2.  Characterisation of the prostanoid receptors mediating contraction of guinea-pig isolated trachea.

Authors:  R A Coleman; I Kennedy
Journal:  Prostaglandins       Date:  1985-03

3.  A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

Authors:  J D Morrow; K E Hill; R F Burk; T M Nammour; K F Badr; L J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 4.  Eicosanoid biosynthesis and action: novel opportunities for pharmacological intervention.

Authors:  S Nicosia; C Patrono
Journal:  FASEB J       Date:  1989-06       Impact factor: 5.191

5.  Actions of the E2-isoprostane, 8-ISO-PGE2, on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor.

Authors:  A W Longmire; L J Roberts; J D Morrow
Journal:  Prostaglandins       Date:  1994-10

6.  Antagonism of prostanoid-induced contractions of rat gastric fundus muscle by SC-19220, sodium meclofenamate, indomethacin or trimethoquinol.

Authors:  A Bennett; C Jarosik; G J Sanger; D E Wilson
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

7.  Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.

Authors:  K Takahashi; T M Nammour; M Fukunaga; J Ebert; J D Morrow; L J Roberts; R L Hoover; K F Badr
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

8.  Antagonism of the thromboxane-sensitive contractile systems of the rabbit aorta, dog saphenous vein and guinea-pig trachea.

Authors:  R L Jones; V Peesapati; N H Wilson
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

9.  The action of prostanoid receptor agonists and antagonists on smooth muscle and platelets.

Authors:  R M Eglen; R L Whiting
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

10.  The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist.

Authors:  J D Morrow; T A Minton; L J Roberts
Journal:  Prostaglandins       Date:  1992-08
View more
  17 in total

1.  Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine.

Authors:  Anaid Shahbazian; Akos Heinemann; Bernhard A Peskar; Peter Holzer
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Regulation of [³H]d-aspartate release by the 5-F(2t)-isoprostane and its 5-epimer in isolated bovine retina.

Authors:  Jamal Jamil; Ashley Wright; Na'cara Harrison; Edem Kegey; Arnecia Faye Flowers; Namonique Jarell Flyod; Casey Kotera; Alexandre Guy; Jean-Marie Galano; Thierry Durand; Ya Fatou Njie-Mbye; Sunny E Ohia; Catherine A Opere
Journal:  Neurochem Res       Date:  2011-11-13       Impact factor: 3.996

Review 3.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

4.  Mechanisms of the prostaglandin F2alpha-induced rise in [Ca2+]i in rat intrapulmonary arteries.

Authors:  Vladimir A Snetkov; Gregory A Knock; Lynne Baxter; Gavin D Thomas; Jeremy P T Ward; Philip I Aaronson
Journal:  J Physiol       Date:  2005-12-15       Impact factor: 5.182

5.  Role of superoxide and thromboxane receptors in acute angiotensin II-induced vasoconstriction of rabbit vessels.

Authors:  Sandra L Pfister; Kasem Nithipatikom; William B Campbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-04-01       Impact factor: 4.733

6.  Role of prostanoid production and receptors in the regulation of retinal endogenous amino acid neurotransmitters by 8-isoprostaglandin E2, ex vivo.

Authors:  Min Zhao; Christopher J Destache; Sunny E Ohia; Catherine A Opere
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

Review 7.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

8.  Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon.

Authors:  A K Bassil; R A Borman; E M Jarvie; R J McArthur-Wilson; R Thangiah; E Z H Sung; K Lee; G J Sanger
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

9.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

10.  Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus.

Authors:  Jian-Xiong Chen; Patrick W O'Mara; Stanley D Poole; Naoko Brown; Noah J Ehinger; James C Slaughter; Bibhash C Paria; Judy L Aschner; Jeff Reese
Journal:  Pediatr Res       Date:  2012-08       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.